Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-IN-19
Country
IN
Application Type
DIV
Patent Status
Pending
Patent Number
Publication Number
Application Number
202118011347
IC
NCI
Date Filed
Date Issued
Patent PDF